First Minister Michelle O’Neill has criticized the decision by Stormont’s health minister to suspend Northern Ireland’s involvement in a clinical trial that evaluates the risks and benefits of puberty-blocking drugs for children questioning their gender. She labeled the decision “disgraceful,” highlighting concerns over the impact on vulnerable young individuals seeking support. The trial aims to provide crucial insights into the treatment of gender dysphoria. O’Neill’s remarks underscore the ongoing debate surrounding transgender healthcare in Northern Ireland.
Want More Context? 🔎
Loading PerspectiveSplit analysis...
